Research programme: neuropeptide Y analogues - Peptech/CRC

Drug Profile

Research programme: neuropeptide Y analogues - Peptech/CRC

Alternative Names: Neuropeptide Y analogues research programme - Peptech/CRC; PTL 041120

Latest Information Update: 17 Jul 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CRC for Biopharmaceutical Research; Peptech
  • Class
  • Mechanism of Action Neuropeptide Y receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rhinitis

Most Recent Events

  • 17 Jul 2001 Discontinued-Preclinical for Rhinitis in Australia (Intranasal)
  • 26 Nov 1998 Peptech seeks development partner for neuropeptide Y analogue
  • 10 Feb 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top